Aptevo Therapeutics Price Chart
*There is no price data available for this ticker
Aptevo Therapeutics Volume Chart
*There is no volume data available for this ticker
Aptevo Therapeutics Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.08(+1.44%)
| Open | $5.22 |
|---|---|
| Close | $5.30 |
| Low | $5.13 |
| Low Change | -0.09 (-1.72%) |
| High | $5.39 |
| High Change | +0.17 (+3.25%) |
| Range | $0.26 |
| Volume | 6.915K |
| Dollar Volume | $36.61K |
Premarket Yesterday
-0.48(-8.76%)
| Open | $5.48 |
|---|---|
| Close | $5.00 |
| Low | $5.00 |
| Low Change | -0.48 (-8.76%) |
| High | $5.48 |
| High Change | +0.00 (+0.00%) |
| Range | $0.48 |
| Volume | 907 |
| Dollar Volume | $4.54K |
Aptevo Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $5.35 |
|---|---|
| 10 Day Moving Average (SMA10) | $4.88 |
| 20 Day Moving Average (SMA20) | $4.56 |
| 50 Day Moving Average (SMA50) | $5.53 |
| 100 Day Moving Average (SMA100) | $9.89 |
| 200 Day Moving Average (SMA200) | $22.32 |
Aptevo Therapeutics Statistics
| Average Volume (30 Days) | 72.62K |
|---|---|
| P/E Ratio (Current) | -.23 |
| EPS (Current) | -$23.30 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 3.57 |
| Current Ratio | 3.82 |
| Quick Ratio | 3.82 |
| Debt to Equity | 0.00 |
| Enterprise Value | -$15.38M |
| EV to EBITDA | 0.59 |
| EV to Sales | — |
| Price to Book | 0.36 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.01% |
| Return on Equity | -1.58% |
Aptevo Therapeutics Stock Splits
There have been 5 stock splits for Aptevo Therapeutics (APVO). The last reverse stock split occured on December 30, 2025 and reduced the outstanding shares at a ratio of 18:1.
| Date | Type | Ratio |
|---|---|---|
| Dec 30, 2025 | Reverse | 18:1 |
| May 27, 2025 | Reverse | 20:1 |
| Dec 4, 2024 | Reverse | 37:1 |
| Mar 6, 2024 | Reverse | 44:1 |
| Mar 27, 2020 | Reverse | 14:1 |
Aptevo Therapeutics Dividends
There have been no dividends for Aptevo Therapeutics (APVO).